Total Payments
$84,809
2024 Payments
$51,886
Companies
4
Transactions
96
Medicare Patients
434
Medicare Billing
$40,595
Payment Breakdown by Category
Other$63,226 (74.6%)
Travel$10,945 (12.9%)
Consulting$7,665 (9.0%)
Food & Beverage$2,933 (3.5%)
Education$40.53 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63,226 | 26 | 74.6% |
| Travel and Lodging | $10,945 | 36 | 12.9% |
| Consulting Fee | $7,665 | 3 | 9.0% |
| Food and Beverage | $2,933 | 29 | 3.5% |
| Education | $40.53 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $76,827 | 74 | $0 (2024) |
| Eli Lilly and Company | $7,833 | 19 | $0 (2024) |
| VIVUS LLC | $133.23 | 2 | $0 (2023) |
| Currax Pharmaceuticals LLC | $15.79 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,886 | 62 | Novo Nordisk Inc ($44,053) |
| 2023 | $23,793 | 25 | Novo Nordisk Inc ($23,660) |
| 2022 | $8,959 | 6 | Novo Nordisk Inc ($8,959) |
| 2021 | $15.79 | 1 | Currax Pharmaceuticals LLC ($15.79) |
| 2019 | $155.77 | 2 | Novo Nordisk Inc ($155.77) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,687.50 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $21.44 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.75 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $1,007.66 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $75.22 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $112.40 | General |
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.75 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,093.75 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $1,431.42 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $1,431.42 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $136.21 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $136.21 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.57 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.75 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $318.92 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.73 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,437.50 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,687.50 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $122.14 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $29.48 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 94 | 148 | $36,462 | $9,044 |
| 2022 | 4 | 111 | 166 | $42,446 | $10,969 |
| 2021 | 5 | 143 | 209 | $30,464 | $14,327 |
| 2020 | 3 | 86 | 131 | $17,086 | $6,255 |
Total Patients
434
Total Services
654
Medicare Billing
$40,595
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 46 | 95 | $22,998 | $6,545 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,880 | $1,374 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 17 | $4,308 | $1,076 | 25.0% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Facility | 2023 | 20 | 20 | $3,276 | $49.24 | 1.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 100 | $23,570 | $6,739 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $4,518 | $1,507 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $5,962 | $1,468 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 20 | $4,393 | $1,204 | 27.4% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Facility | 2022 | 19 | 19 | $4,003 | $49.98 | 1.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 36 | 77 | $9,710 | $5,460 | 56.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 47 | $6,004 | $3,118 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $6,488 | $2,296 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $3,120 | $1,668 | 53.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 21 | $1,434 | $1,038 | 72.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 18 | $1,224 | $712.68 | 58.2% |
| 94690 | Collection and analysis of exhaled air for evaluation of lung function at rest | Facility | 2021 | 12 | 12 | $2,484 | $34.08 | 1.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 50 | $7,188 | $2,537 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 68 | $5,339 | $2,242 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $4,559 | $1,476 | 32.4% |
About Christopher Weber
Christopher Weber is a Pediatrics healthcare provider based in Germantown, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1619140001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Weber has received a total of $84,809 in payments from pharmaceutical and medical device companies, with $51,886 received in 2024. These payments were reported across 96 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($63,226).
As a Medicare-enrolled provider, Weber has provided services to 434 Medicare beneficiaries, totaling 654 services with total Medicare billing of $40,595. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Germantown, WI
- Active Since 04/08/2008
- Last Updated 02/12/2018
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1619140001
Products in Payments
- Wegovy (Drug) $63,129
- Saxenda (Drug) $7,075
- ZEPBOUND (Drug) $6,841
- Ozempic (Drug) $1,372
- QSYMIA (Drug) $133.23
- CONTRAVE (Drug) $15.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Germantown
Dr. Georgina Owusu-Asiedu, Md, MD
Pediatrics — Payments: $4,349
Pediatrics $4,349
Suparna Mullick, Md, MD
Pediatrics — Payments: $4,190
Pediatrics $4,190
Shazia Hussain, Md, MD
Pediatrics — Payments: $2,043
Pediatrics $2,043
Lelon Edwards, Md, MD
Pediatrics — Payments: $1,670
Pediatrics $1,670
Sally Humphrey, Aprn, APRN
Pediatrics — Payments: $1,456
Pediatrics $1,456
David Yanishevski
Pediatrics — Payments: $600.55
Pediatrics $600.55